文献速递脊柱脊髓外科

可燃香烟与加热烟草制品提取物对颈椎脊髓病的影响:体内与体外证据

Cervical myelopathy responses to extracts derived from combustible cigarettes and heated tobacco products: in vivo and in vitro evidence.
PubMed 文献 · J Neurosurg Spine · 2026-07-31

本研究在大鼠颈椎脊髓压迫模型和PC12细胞中比较可燃香烟与加热烟草制品提取物的神经效应,发现两者均加重神经功能恶化,体外均降低神经突长度和细胞活力并增加凋亡,提示加热烟草制品并不比可燃香烟安全。

要点

  • 可燃香烟和加热烟草制品提取物均加重颈椎脊髓病模型大鼠的运动与感觉功能损害。
  • 体外实验中两者均缩短神经突长度、降低细胞活力并增加凋亡率。
  • 对保守治疗的颈椎脊髓病患者应关注所有形式的烟草使用。

核心结论

  • 可燃香烟和加热烟草制品提取物均加重颈椎脊髓病模型的神经功能恶化。
  • 加热烟草制品尽管被认为较安全,其不良效应与可燃香烟相当。
  • 保守治疗的颈椎脊髓病患者需处理所有形式的烟草使用。

研究设计与样本

  • 雄性Sprague Dawley大鼠(8周龄)行椎板切除或颈脊髓压迫术,每5天腹腔注射生理盐水、香烟烟雾提取物或加热烟草制品提取物,持续10周。
  • 体外采用分化的大鼠嗜铬细胞瘤(PC12)细胞暴露于香烟或加热烟草制品提取物24小时。

主要发现

  • 术后10周中位BBB评分:cCM组11(IQR 11-11,p<0.01)和hCM组11(10-11,p<0.01)均低于CM组13(13-15)。
  • 后爪缩足阈值:cCM组中位26.0 g(IQR 26.0-60.0 g,p<0.001)和hCM组26.0 g(26.0-60.0 g,p<0.001)均高于CM组15.0 g(10.0-15.0 g)。
  • 组织学显示神经元丢失增加、灰质空洞形成和白质脱髓鞘。
  • PC12细胞神经突长度:cCSE 13.4±1.1 μm或hCSE 23.7±11.4 μm均低于未处理对照38.2±15.4 μm(均p<0.001)。
  • 细胞活力:cCSE 0.041±0.007或hCSE 0.047±0.007均低于未处理对照0.070±0.015(均p<0.01);凋亡率:cCSE 53.6%±0.8%或hCSE 52.5%±1.2%均高于未处理对照6.1%±1.0%(均p<0.01)。

临床怎么用

  • 对保守治疗的颈椎脊髓病患者,应询问并干预所有形式的烟草使用,包括加热烟草制品。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Degenerative cervical myelopathy (DCM) is a progressive spinal cord disorder, yet modifiable risk factors that accelerate its progression remain poorly understood. While cigarette smoking worsens surgical outcomes, its influence on disease progression under conservative management is unclear. Heated tobacco products (HTPs) are increasingly used worldwide, but their neurological effects remain unexamined. Authors of this study analyzed the effects of extracts derived from combustible cigarettes and HTPs on the progression of cervical myelopathy and determined whether combustible cigarettes and HTPs exert similar effects. METHODS: Male Sprague Dawley rats (8 weeks old) underwent laminectomy only (sham group) or cervical spinal cord compression surgery and received intraperitoneal injections of saline (compression model [CM] group), cigarette smoke extract (CSE; compression model based on combustible cigarettes [cCM group]) or HTP extract (compression model based on heated tobacco products [hCM group]) every 5 days for 10 weeks. Motor and sensory function were assessed using the Basso, Beattie, Bresnahan (BBB) Locomotor Rating Scale and the von Frey test, respectively. Histological evaluation was performed postmortem. In vitro, differentiated rat pheochromocytoma (PC12) cells were exposed to CSEs prepared from combustible cigarettes (cCSE) or HTPs (hCSE), and neurite length, cell viability, and apoptosis rates were assessed after 24 hours. RESULTS: The median BBB scale scores at 10 weeks postoperatively were significantly lower in the cCM (median 11 [IQR 11-11], p < 0.01) and hCM (11 [10-11], p < 0.01) groups than in the CM group (13 [13-15]). Hind paw withdrawal thresholds were higher in the cCM (median 26.0 g [IQR 26.0-60.0 g], p < 0.001) and hCM (26.0 g [26.0-60.0 g], p < 0.001) groups than in the CM group (15.0 g [10.0-15.0 g]). Histological analysis revealed increased neuronal loss, gray matter cavitation, and white matter demyelination. In PC12 cells, both extracts reduced neurite length (cCSE 13.4 ± 1.1 μm or hCSE 23.7 ± 11.4 μm vs untreated control 38.2 ± 15.4 μm, p < 0.001 for both), decreased viability (cCSE 0.041 ± 0.007 or hCSE 0.047 ± 0.007 vs untreated control 0.070 ± 0.015, p < 0.01 for both), and increased apoptosis (cCSE 53.6% ± 0.8% or hCSE 52.5% ± 1.2% vs untreated control 6.1% ± 1.0%, p < 0.01 for both). CONCLUSIONS: Both combustible cigarette and HTP extracts exacerbated neurological deterioration in a cervical myelopathy model. HTPs, despite their perceived safety, exhibited detrimental effects comparable to those from combustible cigarettes. These findings highlight the need to address all forms of tobacco use in patients with DCM treated conservatively.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Kobayashi Y, Tamai K, Iwamae M, et al. Cervical myelopathy responses to extracts derived from combustible cigarettes and heated tobacco products: in vivo and in vitro evidence. J Neurosurg Spine. 2026. PMID: 42537232. doi:10.3171/2026.2.SPINE251111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。